Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk.

OBJECTIVES To determine the prevalence of ankle-brachial index (ABI)<0.9 and symptomatic peripheral arterial disease (PAD), association with cardiovascular risk factors (CVRF), and impact of adding ABI measurement to coronary heart disease (CHD) risk screening. DESIGN Population-based cross-sectional survey of 6262 participants aged 35-79 in Girona, Spain. METHODS Standardized measurements (CVRF, ABI, 10-year CHD risk) and history of intermittent claudication (IC), CHD, and stroke were recorded. ABI<0.9 was considered equivalent to moderate-to-high CHD risk (> or =10%). RESULTS ABI<0.9 prevalence was 4.5%. Only 0.62% presented low ABI and IC. Age, current smoker, cardiovascular disease, and uncontrolled hypertension independently associated with ABI<0.9 in both sexes; IC was also associated in men and diabetes in women. Among participants 35-74 free of cardiovascular disease, 6.1% showed moderate-to-high 10-year CHD risk; adding ABI measurement yielded 8.7%. Conversely, the risk function identified 16.8% of these participants as having 10-year CHD risk>10%. In participants 75-79 free of cardiovascular disease, the prevalence of ABI<0.9 (i.e., CHD risk> or =10%) was 11.9%. CONCLUSIONS ABI<0.9 is relatively frequent in those 35-79, particularly over 74. However, IC and CHD risk> or =10% indicators are often missing. Adding ABI measurement to CHD-risk screening better identifies moderate-to-high cardiovascular risk patients.

[1]  M. Grau,et al.  Rendimiento de la estimación del riesgo cardiovascular en España mediante la utilización de distintas funciones , 2007 .

[2]  I. Chetter,et al.  A non-randomised controlled trial of the clinical and cost effectiveness of a Supervised Exercise Programme for claudication. , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[3]  J. Murabito,et al.  Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. , 2002, American heart journal.

[4]  Shah Ebrahim,et al.  European guidelines on cardiovascular disease prevention in clinical practice: executive summary. , 2007, Atherosclerosis.

[5]  Sonia S. Anand,et al.  Sensitivity and Specificity of the Ankle–Brachial Index to Predict Future Cardiovascular Outcomes: A Systematic Review , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[6]  Elizabeth Selvin,et al.  Prevalence of and Risk Factors for Peripheral Arterial Disease in the United States: Results From the National Health and Nutrition Examination Survey, 1999–2000 , 2004 .

[7]  J. Knottnerus,et al.  The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease. , 1996, International journal of epidemiology.

[8]  R. D'Agostino,et al.  Concept and usefulness of cardiovascular risk profiles. , 2004, American heart journal.

[9]  M. Chiariello,et al.  Prevalence, risk factors and cardiovascular comorbidity of symptomatic peripheral arterial disease in Italy. , 2004, Atherosclerosis.

[10]  J. Allenberg,et al.  High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. , 2004, Atherosclerosis.

[11]  Janet B. Dunbar,et al.  Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. , 1996, International journal of epidemiology.

[12]  O. Rolandsson,et al.  A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. , 2007, Journal of vascular surgery.

[13]  K. Jaeger,et al.  Trans-atlantic conference on clinical trial guidelines in PAOD (Peripheral arterial occlusive disease) clinical trial methodology. , 1999, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[14]  Seppo Lehto,et al.  Gender difference in the impact of type 2 diabetes on coronary heart disease risk. , 2004, Diabetes care.

[15]  J. Marrugat,et al.  Estimacin del riesgo coronario en Espaa mediante la ecuacin de Framingham calibrada , 2003 .

[16]  R. Elosua,et al.  Trends in cardiovascular risk factor prevalence (1995-2000-2005) in northeastern Spain , 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[17]  R. Prescott,et al.  Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. , 1991, International journal of epidemiology.

[18]  D. Singer,et al.  Management of hypertension in peripheral arterial disease: does the choice of drugs matter? , 2008, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[19]  Richard B Devereux,et al.  Relationship of High and Low Ankle Brachial Index to All-Cause and Cardiovascular Disease Mortality: The Strong Heart Study , 2004, Circulation.

[20]  Ralph B D'Agostino,et al.  EVIDENCE BASED PUBLIC HEALTH POLICY AND PRACTICE Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA study , 2006 .

[21]  Shah Ebrahim,et al.  European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invit , 2007, European heart journal.

[22]  Jeroen J. Bax,et al.  Prognostic significance of declining ankle-brachial index values in patients with suspected or known peripheral arterial disease. , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[23]  Arno W. Hoes,et al.  Peripheral arterial disease in the elderly: The Rotterdam Study. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[24]  A. Hofman,et al.  Determinants of peripheral arterial disease in the elderly: the Rotterdam study. , 2000, Archives of internal medicine.

[25]  V. Giusti Management of obesity in patients with peripheral arterial disease. , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[26]  J. Wilson Peripheral Arterial Disease , 2007, Annals of Internal Medicine.

[27]  W. Hiatt,et al.  Medical treatment of peripheral arterial disease and claudication. , 2001, The New England journal of medicine.

[28]  J. Marrugat,et al.  The association of peripheral arterial occlusive disease with major coronary events in a mediterranean population with low coronary heart disease incidence. , 2008, European Journal of Vascular and Endovascular Surgery.

[29]  F. Fowkes,et al.  The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. , 1992, Journal of clinical epidemiology.

[30]  Rafael Lozano,et al.  AGE STANDARDIZATION OF RATES: A NEW WHO STANDARD , 2000 .

[31]  V. Fuster,et al.  Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. , 2000, Circulation.

[32]  John V. White,et al.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[33]  A Hofman,et al.  Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. , 2008, JAMA.